Dr. Chi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
240 E 38th St
Fl 19
New York, NY 10016Phone+1 646-501-4802Fax+1 646-754-9696
Education & Training
Dana-Farber Cancer InstituteFellowship, Neuro-Oncology, 2006 - 2008
Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolChief Residency, Neurology, 2005 - 2006- Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 2003 - 2005
Massachusetts General HospitalInternship, Internal Medicine, 2002 - 2003
Chicago Medical School at Rosalind Franklin University of Medicine and ScienceClass of 2002
Certifications & Licensure
NY State Medical License 2015 - 2019
MA State Medical License 2006 - 2017
Awards, Honors, & Recognition
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012
Clinical Trials
- A Study of Ad-RTS-hIL-12 With Veledimex in Subjects With Glioblastoma or Malignant Glioma Start of enrollment: 2015 Jun 01
- Efficacy and Safety of the Combination Therapy of Dabrafenib and Trametinib in Subjects With BRAF V600E- Mutated Rare Cancers Start of enrollment: 2014 Mar 12
- The Toca 5 Trial: Toca 511 & Toca FC Versus Standard of Care in Patients With Recurrent High Grade Glioma Start of enrollment: 2015 Nov 30
- Join now to see all
Publications & Presentations
PubMed
- 298 citationsExtreme Vulnerability of IDH1 Mutant Cancers to NAD+ DepletionKensuke Tateishi, Hiroaki Wakimoto, A. John Iafrate, Shota Tanaka, Franziska Loebel
Cancer Cell. 2015-12-14 - 125 citationsTargetable signaling pathway mutations are associated with malignant phenotype in IDH-mutant gliomasHiroaki Wakimoto, Shota Tanaka, William T. Curry, Franziska Loebel, Dan Zhao
Clinical Cancer Research. 2014-06-01 - 102 citationsMyc-Driven Glycolysis Is a Therapeutic Target in GlioblastomaKensuke Tateishi, A. John Iafrate, Quan H Ho, William T. Curry, Tracy T. Batchelor
Clinical Cancer Research. 2016-09-01
Journal Articles
- Predicting Genotype and Survival in Glioma Using Standard Clinical MR Imaging Apparent Diffusion Coefficient Images: A Pilot Study from the Cancer Genome AtlasD Zagzag, M Snuderl, A S Chi, American Journal of Neuroradiology
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
